Shacham Sharon 4
4 · Karyopharm Therapeutics Inc. · Filed Mar 23, 2021
Insider Transaction Report
Form 4
Shacham Sharon
Chief Scientific Officer
Transactions
- Sale
Common Stock
[F1][F2]2021-03-18$12.39/sh−4,000$49,553→ 714,826 total(indirect: By Spouse)
Holdings
- 920,152
Common Stock
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person.
- [F2]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.29 to $12.56, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Signature
/s/ Nancy Smith as Attorney-in-Fact for Sharon Shacham|2021-03-23